Role of amylin in nutrient intake - Animal studies

Diabetic Medicine

Volumn 14, Issue SUPPL. 2, 1997, Pages

  Young, A ^a  

^a AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

Amylin; Animal studies; Gastric emptying; Glucagon; Satiety

Indexed keywords

AMYLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA POSTREMA; ARTICLE; CARBOHYDRATE METABOLISM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; DRUG EFFECT; HORMONE RESPONSE; NONHUMAN; NUTRIENT; PANCREAS ISLET BETA CELL; SATIETY; STOMACH EMPTYING;

AMYLOID; ANIMAL NUTRITION PHYSIOLOGY; ANIMALS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; EATING; GASTRIC EMPTYING; GLUCAGON; HUMANS; HYPOGLYCEMIC AGENTS; RECEPTORS, PEPTIDE;

EID: 0030806396     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199706)14:2+3.0.CO;2-Q     Document Type: Article

References (51)

1. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KB. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 1987; 84: 8628-8632.
2. Rink TJ, Beaumont K, Koda J, Young A. Structure and biology of amylin. Trends Pharmacol Sci 1993; 14: 113-118.
3. Young A, Pittner R, Gedulin B, Vine W, Rink T. Amylin regulation of carbohydrate metabolism. Biochem Soc Trans 1995; 23: 325-331.
4. Young AA, Bogardus C, Stone K, Mott DM. Insulin response of components of whole-body and muscle carbohydrate metabolism in humans. Am J Physiol 1988; 254: E231-E236.
5. Brener W, Hendrix TR, McHugh PR. Regulation of the gastric emptying of glucose. Gastroenterology 1983; 85: 76-82.
6. Hunt J, Stubbs D. The volume and energy content of meals as determinants of gastric emptying. J Physiol 1975; 245: 209-225.
7. Lin HC, Elashoff JD, Gu YG, Meyer JH. Nutrient feedback inhibition of gastric emptying plays a larger role than osmotically dependent duodenal resistance. Am J Physiol 1993; 265: G672-G676.
8. Maerz LL, Sankaran H, Scharpf SJ, Deveney CW. Effect of caloric content and composition of a liquid meal on gastric emptying in the rat. Am J Physiol 1994; 36: R1163-R1167.
9. Vist GE, Maughan RJ. The effect of osmolality and carbohydrate content on the rate of gastric emptying of liquids in man. J Physiol (Lond) 1995; 486: 523-531.
10. Young AA, Gedulin BR, Rink TJ. Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake. Metabolism 1996; 45: 1-3.
11. Gedulin BR, Jodka CM, Greene DL, Young AA. Comparison of 21 peptides on inhibition of gastric emptying in conscious rats. Digestive Disease Week, American Association for the Study of Liver Disease, American Gastroenterological Association, 1996; A-742 (abstract).
12. Brown K, Menius A, Sandefer E, Edwards J, James M. The effects of amylin on changes in plasma glucose and gastric emptying following an oral glucose load in conscious dogs. Diabetes 1994; 43 (suppl 1): 172A (abstract).
13. Kolterman O, Gottlieb A, Moyses C. Amylin agonist, AC-137, reduces postprandial hyperglycemia in subjects with insulin dependent diabetes mellitus (IDDM). Diabetes 1994; 43 (suppl 1): 78A (abstract).
14. Young AA, Vine W, Gedulin BR, et al. Preclinical pharmacology of pramlintide in the rat: comparisons with human and rat amylin. Drug Develop Res 1996; 37: 231-248.
15. Kolterman OG, Gottlieb A, Moyses C, Colburn W. Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue. Diabetes Care 1995; 18: 1179-1182.
16. Young AA, Gedulin B, Vine W, Percy A, Rink TJ. Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia 1995; 38: 642-648.
17. Pieber TR, Roitelman J, Lee Y, Luskey KL, Stein DT. Direct plasma radioimmunoassay for rat amylin-(1-37): Concentrations with acquired and genetic obesity. Am J Physiol 1994; 267: E156-E164.
18. Huang HS, Cooper GJS, Young AA, Johnson MJ. Deficiency of amylin expression in the pancreas of auto-immune BB/W or diabetic rats. J Cell Biochem 1991; 15 (suppl): 67.
19. Nowak TV, Roza AM, Weisbruch JP, Brosnan MR. Accelerated gastric emptying in diabetic rodents: effect of insulin treatment and pancreas transplantation. J Lab Clin Med 1994; 123: 110-116.
20. Pehling G, Tessari P, Gerich JE, Haymond MW, Service FJ, Rizza RA. Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. J Clin Invest 1984; 74: 985-991.
21. Nowak TV, Johnson CP, Kalbfleisch JH, et al. Highly variable gastric emptying in patients with insulin dependent diabetes mellitus. Gut 1995; 37: 23-29.
22. Young AA, Gedulin B, Gaeta LSL, et al. Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat. Evidence for a metabolic role of endogenous amylin. FEBS Lett 1994; 343: 237-241.
23. Gedulin B, Green D, Jodka L, Young A. Endogenous amylin and gastric emptying in rats: comparison with GLP-1 and CCK-8. Diabetologia 1995; 38 (suppl 1): A244 (abstract).
24. Ritzel R, Orskov C, Hoist JJ, Nauck MA. Pharmacokinetic, insulinotropic and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response relationships. Diabetologia 1995; 38: 720-725.
25. Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA. Gastric emptying glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (non-insulin-dependent) diabetic patients. J Clin Endocrinol Metab 1996; 81: 327-332.
26. Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993; 36: 741-744.
27. Liddle RA, Rushakoff RJ, Morita ET, Beccaria L, Carter JD, Goldfine ID. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans. J Clin Invest 1988; 81: 1675-1681.
28. Rink TJ, Beaumont K, Koda J, Young A. Structure and biology of amylin. Trends Pharmacol Sci 1993; 14: 113-118.
29. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V. Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 1993; 138: 159-166.
30. Liddle RA, Rushakoff RJ, Morita ET, Beccaria L, Carter JD, Goldfine ID. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans. J Clin Invest 1988; 81: 1675-1681.
31. Jodka C, Green D, Young A, Gedulin B. Amylin modulations of gastric emptying in rats depends upon an intact vagus nerve. Diabetes 1996; 45 (suppl 1): 235A (abstract).
32. Schvarcz E, Palmer M, Aman J, Berne C. Hypoglycemia increases the gastric emptying rate in healthy subjects. Diabetes Care 1995; 18: 674-676.
33. Young A, Gedulin B, Jodka C, Green C. Insulin-induced hypoglycemia reverses amylin-inhibition of gastric emptying in rats. Diabetes 1996; 45 (suppl 2): 187A (abstract).
34. Beaumont K, Kenney MA, Young AA, Rink TJ. High affinity amylin binding sites in rat brain. Mol Pharmacol 1993; 44: 493-497.
35. Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K. In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 1994; 62: 553-567.
36. Bueno L. Assessment of CNS control of gastrointestinal motility. In: Gaginell TS (ed). Handbook of Methods in Gastrointestinal Pharmacology. Boca Raton: CRC Press, 1996, pp 297-330.
37. Chance WT, Balasubramaniam A, Stallion A, Fischer JE. Anorexia following the systemic injection of amylin. Brain Res 1993; 607: 185-188.
38. Morley JE, Flood JF. Amylin decreases food intake in mice. Peptides 1991; 12: 865-869.
39. Lutz TA, Delprete E, Scharrer E. Reduction of food intake in rats by intraperitoneal injection of low doses of amylin. Physiol Behav 1994; 55: 891-895.
40. Bhavsar S, Watkins J, Rink T. Synergistic effect of amylin and cholecystokinine octapeptide on food intake in mice. Diabetes 1996; 45 (suppl 1): 333A (abstract).
41. Turton MD, O'Shea D, Gunn I, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996; 379: 69-72.
42. Bhavsar SP, Gedulin BR, Beaumont K, Rink TJ, Young AA. Inhibition of gastric emptying and of food intake appear to be independently controlled in rodents. Soc Neurosci Abstr 1995; 21: 459 (abstract).
43. Birkemo LS, Johnson MF, Ervin GN. CCK-8 and amylin produce different patterns of effects on anorexia and delayed gastric emptying. Soc Neurosci Abstr 1995; 21: 459 (abstract).
44. Arnelo LJ, Permert J, Adrian TE, Larsson J, Westermark P, Reidelberger RD. Anorexia following chronic infusion of islet amyloid polypeptide in rats. Am J Physiol 1996; 271: R1654-R1659.
45. DeFronzo RA, Ferrannini E, Simonson DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 1989; 38: 387-395.
46. Unger RJ, Orci L. The role of glucagon in the endogenous hyperglycemia of diabetes mellitus. Ann Rev Med 1977; 28: 119-130.
47. Brand CL, Rolin B, Jorgensen PN, Svendsen I, Kristensen JS, Holst JJ. Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats. Diabetologia 1994; 37: 985-993.
48. Unger RH, Foster DW. Diabetes mellitus. In: Wilson JD, Foster DW (eds). Williams Textbook of Endocrinology. Philadelphia: WB Saunders Company, 1992, pp 1273-1275.
49. Samois E, Bonner-Weir S, Weir GC. Intra-islet insulin-glucagon-somatostatin relationships. Clin Endocrinol Metab 1986; 15: 33-58.
50. Gedulin BR, Young AA. Dose-response for glucagonostatic effect of amylin in rats. Metabolism 1997; 46: 67-70.
51. Gedulin BR, Percy A, Jodka CM, Young AA. Evidence from studies using neutralizing antibody and the antagonist AC187 that endogenous amylin inhibits glucagon secretion. Diabetes 1997; in press.